Data sharing: An ethical and scientific imperative

JAMA - Journal of the American Medical Association

Volumn 315, Issue 12, 2016, Pages 1237-1239

  Bauchner, Howard ^a   Golub, Robert M ^a   Fontanarosa, Phil B ^a  

^a JAMA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCESS TO INFORMATION; CLINICAL TRIAL (TOPIC); CONFLICT OF INTEREST; DATA BASE; DATA PROCESSING; DRUG INDUSTRY; DRUG RESEARCH; EDITORIAL; HEALTH EDUCATION; HUMAN; INFORMATION DISSEMINATION; KNOWLEDGE; MEDICAL CARE; MEDICAL ETHICS; MEDICAL INFORMATION; MEDICAL LITERATURE; METHODOLOGY; PATIENT CARE; PRIORITY JOURNAL; PUBLICATION; RISK BENEFIT ANALYSIS; SCIENTIFIC LITERATURE; ANONYMIZATION; ETHICS; PUBLISHING; RESEARCH SUBJECT; SOCIAL BEHAVIOR; STANDARDS; STATISTICAL ANALYSIS;

CLINICAL TRIALS AS TOPIC; DATA ANONYMIZATION; DATA INTERPRETATION, STATISTICAL; HUMANS; INFORMATION DISSEMINATION; PUBLICATION BIAS; RESEARCH SUBJECTS; SOCIAL RESPONSIBILITY;

EID: 84962228672     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2016.2420     Document Type: Editorial

References (15)

1. Ross JS, Krumholz HM. Ushering in a new era of open science through data sharing: the wall must come down. JAMA. 2013;309(13):1355-1356.
2. Lo B. Sharing clinical trial data: maximizing benefits, minimizing risk. JAMA. 2015;313(8):793-794.
3. Krumholz HM, Peterson ED. Open access to clinical trials data. JAMA. 2014;312(10):1002-1003.
4. Christakis DA, Zimmerman FJ. Rethinking reanalysis. JAMA. 2013;310(23):2499-2500.
5. Longo DL, Drazen JM. Data sharing. N Engl J Med. 2016;374(3):276-277.
6. Navar AM, Pencina MJ, Rymer JA, Louzao DM, Peterson ED. Use of open access platforms for clinical trial data. JAMA. doi:10.1001/jama.2016.2374.
7. Ebrahim S, Sohani ZN, Montoya L, et al. Reanalyses of randomized clinical trial data. JAMA. 2014;312(10):1024-1032.
8. Chavalarias D, Wallach JD, Li AHT, Ioannidis JPA. Evolution of reporting P values in the biomedical literature, 1990-2015. JAMA. 2016;315(11):1141-1148.
9. Berlin JA, Golub RM. Meta-analysis as evidence: building a better pyramid. JAMA. 2014;312(6): 603-605.
10. Karha J, Topol EJ. The sad story of Vioxx, and what we should learn from it. Cleve Clin J Med. 2004;71(12):933-939.
11. Loder E, Tovey D, Godlee F. The Tamiflu trials. BMJ. 2014;348:g2630. doi:10.1136/bmj.g2630.
12. Taichman DB, Backus J, Baethge C, et al. Sharing clinical trial data: a proposal from the International Committee of Medical Journal Editors. JAMA. 2016;315(5):467-468.
13. Committee on Strategies for Responsible Sharing of Clinical Trial Data. Sharing clinical trial data: maximizing benefits, minimizing risk. IOM website. http://iom.nationalacademies.org/Reports/2015/Sharing-Clinical-Trial-Data.aspx. Accessed March 1, 2016.
14. Publication and access to clinical data: an inclusive development process. European Medicines Agency website. http://www.ema.europa.eu/ema/index.jsp?curl=pages/special-topics/general/general-content-000556.jsp. Accessed March 1, 2016.
15. de Montjoye Y-A, Radaelli L, Singh VK, Pentland AS. Identity and privacy-unique in the shopping mall: on the reidentifiability of credit card metadata. Science. 2015;347(6221):536-539.